Dozens of patients are suing Eli Lilly and Novo Nordisk, the two companies that make GLP-1 drugs to treat diabetes and weight loss, claiming they suffered distressing digestive symptoms, such as gallbladder removal or gastroparesis, after taking the medication
For example, semaglutide (Wegovy) can be used as a treatment for Type 2 diabetes alongside being a licensed weight loss drug
Using it past its expiration date can be risky
Read before you choose Understanding GLP-1 basics, eligibility, costs, and safety helps you evaluate any provider more carefully
Because both are CNS stimulants with overlapping mechanisms, co-administration significantly elevates the risk of cardiovascular events, including dangerously elevated heart rate, high blood pressure, and arrhythmia
In support, recently BPC 157 increased the survival rate of cultured enteric neurons and the proliferation rate of cultured enteric glial cells (Wang et al., 2019)